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Human cardiac troponin T has been isolated and its properties compared with those of rabbit skeletal and bovine cardiac troponin T. Seven 
monoclonal antibodies to troponin T have been obtained. Two antibodies cross-reacted with both cardiac and skeletal troponin T and recognized 
epitopes located between residues 98-177 of bovine cardiac troponin T. Five other antibodies were specific for cardiac troponin T and recognized 
antigenic determinants located between residues 180-258 of bovine cardiac troponin T. Localization of antigenic determinants in the central part 
of troponin T seems to be due to the high hydrophilicity and flexibility of this part of the molecule. The monoclonal antibodies thus obtained may 
be used for diagnosing various types of human heart diseases. 
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1. INTRODUCTION University). The phosphorylation conditions were similar to those 
described earlier [8]. 
The troponin-tropomyosin complex is involved in 
the regulation of actin-myosin interactions in skeletal 
and cardiac muscles [1,2]. Troponin T, one of the three 
troponin components, is a structural protein interacting 
with actin and tropomyosin [ 1,2]. There are no less than 
three genes coding troponin T of fast and slow skeletal 
and heart muscle [3]. Troponin T mRNA undergoes 
alternative splicing which leads to the formation of a 
great number of troponin T isoforms [4,5]. Recently 
obtained antibodies specifically interacting with human 
cardiac troponin T were successfully used for the detec- 
tion of heart damage [6,7]. The primary structure of 
human cardiac and skeletal troponin T is still unknown. 
This paper deals with the isolation of preparative quan- 
tities of human cardiac troponin T and preparation and 
characterization of monoclonal antibodies against this 
protein. 
To localize antigenic determinants, troponin T phosphorylated by 
one of the protein kinases mentioned above was either cleaved by 
CNBr [12] or subjected to limited chymotrypsinolysis [13]. Peptides 
thus obtained were subjected to SDS-gel electrophoresis [14,15]. After 
staining with Coomassie R-250, the gels were dried and autoradio- 
graphed. 
Monoclonal antibodies were obtained by the method of Kohler and 
Milshtein [16] using bovine cardiac and human cardiac troponin T as 
antigens. Antibody isotypes were determined using the Calbiochem 
kit. Screening of the primary clones and determination of the antibody 
specificity was performed by the solid-phase immunoenzyme method, 
with rabbit skeletal, bovine, and human cardiac troponin T as anti- 
gens. After electrophoresis troponin T and its peptides were trans- 
ferred to nitrocellulose filters by semi-dry blotting [17]. The nitrocellu- 
lose filters were incubated with ascite fluids at a l:l,OOO dilution for 
1 h and after washing treated with anti-mouse antibodies conjugated 
with peroxidase. The blots were stained in /3-naphtol-containing me- 
dium. 
Determination of sites with the highest hydrophilicity and highest 
flexibility within the structure of cardiac troponin T was performed 
by the PC Gene program (subprograms Flexpro and Antigen). 
2. MATERIALS AND METHODS 3. RESULTS 
Rabbit skeletal and bovine cardiac troponin T were isolated as 
described earlier [8,9]. The method of human cardiac troponin T 
purification consists of extraction, heat treatment, ammonium 
sulphate fractionation and ion-exchange chromatography. The details 
of purification will be published elsewhere. Isolated troponin T was 
phosphorylated by casein kinase II from rat liver [lo] or by 
phosphorylase kinase from rabbit skeletal muscle [l l] kindly provided 
by Dr. P.L. Vulfson (Department of Biochemistry, Moscow State 
3.1. Isolation of human cardiac troponin T and investiga- 
tion of its properties 
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The method developed allows homogeneous troponin 
T to be obtained (see Fig. 1). We were unable to detect 
human cardiac troponin T isoforms by either ion-ex- 
change chromatography or SDS-gel electrophoresis. 
These data agree well with the results of Anderson et al. 
[ 181 which indicated that normal human hearts predom- 
inantly contain one isoform of troponin T. 
We compared the structures of troponin T isolated 
from bovine and human heart and rabbit skeletal mus- 
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Fig. 1. Electrophoregrams (c) and autoradiograms (p)of native troponin T (1) and its chymotryptic peptides (2). A, B and C are rabbit skeletal, 
bovine and human cardiac troponin T, respectively. On the right is a scale of apparent molecular weights. 
cle using one-dimensional peptide mapping. Chymot- 
rypsinolysis of rabbit skeletal troponin T produced two 
fragments, i.e. TnT,, containing residues 1-158 (M, 23 
kDa), and TnT,, containing residues 159-259 (M, 14 
kDa) (Fig. 1). Casein kinase II phosphorylates only 
Ser-1 of both cardiac and skeletal troponin T [8], there- 
fore only TnT, contains the radioactive phosphate 
(Figs. lA, 2). One-dimensional chymotryptic peptide 
maps of human and bovine cardiac troponins T are 
similar (cf. Fig. lB,C) but differ from those of rabbit 
skeletal troponin T. Chymotrypsinolysis of cardiac tro- 
ponin T produces a number of N-terminal peptides with 
M, in the range of 35-24 kDa, containing the site 
A 
phosphorylated by casein kinase II (Fig. lB,C), but no 
peptides with M, 14 kDa, analogous to the C-terminal 
TnT, fragment of skeletal troponin T. The pattern of 
CNBr-peptides of bovine and human cardiac troponin 
T is also very similar. The only difference is that human 
cardiac troponin T contains a very short (M, < 4 kDa) 
CNBr peptide which is absent in the case of bovine 
cardiac troponin T. This peptide contains sites 
phosphorylated by casein kinase II; therefore we pre- 
sume that human cardiac troponin T contains an addi- 
tional Met residue close to the N-terminus which is 
absent in the primary structure of bovine cardiac tro- 
ponin T. 
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Fig. 2. Electrophoretic separation of CNBr-peptides of rabbit skeletal (A) and bovine cardiac troponins T (B). Electrophoresis was performed by 
the method of Schagger and von Jagow [16]. Lane I, gels stained with Coomassie R-250; lanes 2 and 3, autoradiograms after electrophoresis of 
CNBr-peptides of troponin T phosphorylated by phosphorylase kinase and casein kinase II, respectively. On the right is a scale of apparent 
molecular weights. 
26 
Volume 3 15, number 1 FEBS LETTERS January 1993 
3.2. Ident$cation of troponin T peptides on SDS-poly- Table I 
acrylamide gels 
Since the structure of bovine cardiac troponin T is 
similar to that of human cardiac troponin T, the greater 
part of this investigation was performed on rabbit skel- 
etal and bovine cardiac troponin T. Cleavage of rabbit 
skeletal troponin T with CNBr resulted in the formation 
ofpeptidesofM,26,24, 16, 13.5, 10.5,8.0,and5.9kDa. 
The bands migrating with M, 13.5, 8.0 and 5.9 are dou- 
blets. Two CNBr-peptides of troponin T, CB5 (residues 
152-175) and CB6 (residues 239-259), migrate in the 
region of M, 5.9 kDa. One of these peptides, CB5, con- 
tains sites (Ser- 156/Ser-157) phosphorylated by 
phosphorylase kinase [12] (Fig. 2A2). The 8 kDa pep- 
tide does not contain any sites of phosphorylation and 
corresponds to the CB4 peptide (residues 176230) of 
rabbit skeletal troponin T. The 10.5 kDa peptide con- 
tains sites phosphorylated by phosphorylase kinase 
and, according to its size, corresponds to the uncleaved 
fragment, including peptides CB5 and CB4 (residues 
152-230). The lower band of M, 13.5 kDa contains sites 
phosphorylated by phosphorylase kinase and corre- 
sponds to the CB2 peptide (residues 71-151). The pep- 
tide of a slightly higher M,, badly stained with Coomas- 
sie R-250, contains sites phosphorylated by casein ki- 
nase (Fig. 2A3) and corresponds to peptide CB3 (resi- 
dues l-70) of rabbit skeletal troponin T. All other high 
molecular weight peptides are the products of incom- 
plete digestion. The pattern of CNBr-peptides and their 
relative electrophoretic mobilities correlate well with the 
data of [19]. 
Some properties and the specificity of monoclonal antibodies to tro- 
ponin T 
Clone Ig type Specificity for Localization of 
troponin T epitope. in 
bovine cardiac 
Bovine Human Rabbit troponin T 
cardiac cardiac skeletal 
4Dll IgG*b 100 105 105 98-178 
llDE4 IgG2b 100 120 120 98-178 
2EGll IgG*, 100 75 5 18&258 
1 lGD5 IgG,, 100 120 4 18&258 
5C12 IgM 100 125 9 180-258 
4Cll IgM 100 60 8 204258 
lF2 IgG, 100 105 4 204258 
The specificity was determined by the ELISA method, the intensity of 
bovine cardiac troponin T staining was taken for 100%. 
ponin T (Table I). These antibodies stained CNBr-pep- 
tides of troponin T with M, > 13 kDa (Fig. 3A) and did 
not interact with either CBl (M, 11 kDa) or CB2 (M, 
5.2) peptides of cardiac troponin T. The data presented 
indicate that these antibodies interact with the epitope 
located between residues 71-151 of rabbit skeletal tro- 
ponin T or in the homologous region (residues 98-178) 
of bovine cardiac troponin T. 
CNBr-peptide maps of bovine cardiac troponin T are 
far less informative. Usually we detected the bands of 
M, 28, 16.5, 13.2-13.6, 11 and 5.2 kDa on the gels. The 
smallest peptide of A4, 5.2 kDa does not contain phos- 
phorylation sites and is identical to CB2 peptide (resi- 
dues 69-92) of bovine cardiac troponin T [20]. A badly 
stained peptide of M, 11 kDa contains the sites 
phosphorylated by casein kinase II and seems to corre- 
spond to the CBl peptide (residues l-68). The peptides 
migrating in the region of 13.2-13.6 kDa contain sites 
phosphorylated by both kinases (Fig. 2B2,3). We pre- 
sume that this region contains peptide CB3 (residues 
93-178, including Ser-176 which is phosphorylated by 
phosphorylase kinase), a partly hydrolyzed fragment 
containing residues l-92 (peptides CB l-CB2 with Ser- 1 
phosphorylated by casein kinase II), as well as the CB4 
peptide (residues 180-284) which is not phosphorylated 
by either protein kinases. The other peptides of higher 
M, are the products of incomplete digestion. 
Antibodies 2EG11, 11 GD5 and 5C12 specifically in- 
teract with cardiac troponin T (Table I). These antibod- 
ies weakly stained CNBr-peptides of skeletal troponin 
T with M, 10.5 kDa (CB5-CB4, residues 152-230) and 
effectively interacted with the homologous region of 
cardiac troponin T (residues 180-258) included in the 
CB4 peptide with M, 13 kDa (Fig. 3B). 
Antibodies lF2 and 4Cll are also specific to cardiac 
troponin T (Table I). These antibodies weakly stained 
TnT, and CNBr-peptides (M, 10.5 and 8.0 kDa) of 
skeletal troponin T and interacted with a 13 kDa CNBr- 
peptide of cardiac troponin T (Fig. 3C). This means that 
antibodies lF2 and 4Cll interact with the epitope lo- 
cated between residues 176230 of skeletal troponin T 
and the homologous fragment of cardiac troponin T 
(residues 204258). 
4. DISCUSSION 
3.3. Localization of epitopes recognized by monoclonal 
antibodies within the structure of troponin T 
After primary screening we selected seven clones pro- 
ducing antibodies effectively reacting with cardiac tro- 
ponin T. Two clones, 1 lDE4 and 4D11, produced anti- 
bodies which recognize both skeletal and cardiac tro- 
There are only a few preliminary reports on the prep- 
aration of monoclonal antibodies against cardiac tro- 
ponin T [6,7,21]. Katus and co-workers [6,7,22] devel- 
oped a sensitive and reliable immunological method for 
determination of cardiac troponin T in the blood. How- 
ever, there were no data on the localization of epitopes 
recognized by cardiac troponin T antibodies. Therefore 
we prepared a panel of monoclonal antibodies and de- 
termined the epitopes recognized by these antibodies in 
cardiac and skeletal troponin T. To our surprise all 
antibodies predominantly interact with the central part 
27 
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Fig. 3. Immunoblots after staining of CNBr (lanes 1,2) and chymotryptic (lanes 3,4) peptides of rabbit skeletal (lanes 1,3) and bovine cardiac (lanes 
2,4) troponin T with monoclonal antibodies llED4 (A), 2EGll (B) and lF2 (C). 
of the troponin T molecule (Table I). To explain the 
uneven distribution of antigenic determinants we ana- 
lyzed the primary structure of bovine cardiac troponin 
T using the PC Gene program. The peptides containing 
residues 110-116, 140-145, 155-160, and 200-206, are 
the most hydrophilic and the regions restricted by resi- 
dues 44-50, 109-115, 157-163, 192-198 and 206206 
are characterized by high flexibility. Hydrophilic and 
flexible regions located on the protein surface are, as a 
rule, highly antigenic [23], therefore it is no surprise that 
all our antibodies predominantly interact with the part 
of the cardiac troponin T molecule restricted by residues 
98-258. 
In future we are planning to use the antibodies ob- 
tained for determining cardiac troponin T in serum with 
its further application in the diagnosis of myocardial 
damage. 
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